Takahiro Osuga

680 total citations
30 papers, 486 citations indexed

About

Takahiro Osuga is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takahiro Osuga has authored 30 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takahiro Osuga's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Takahiro Osuga is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Glycosylation and Glycoproteins Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Takahiro Osuga collaborates with scholars based in Japan and Egypt. Takahiro Osuga's co-authors include Koji Miyanishi, Junji Kato, Masayoshi Kobune, Kohichi Takada, Kazuyuki Murase, Satoshi Iyama, Yasushi Sato, Masahiro Hirakawa, Rishu Takimoto and Tsuyoshi Hayashi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Takahiro Osuga

26 papers receiving 483 citations

Peers

Takahiro Osuga

ONCOL

PRM

IMMUN

SURGE

Naotaka Hayasaka Japan

Bettina Baron‐Lühr Germany

Yulong Tan China

Yohei Arihara Japan

Rossella Solmi Italy

Peng Fu China

Akio Matsushita Japan

Tian Liu China

Marc Llort Asens Finland

Josette Northcott United States

Naotaka Hayasaka Japan

Takahiro Osuga

189 ×1.0

134 ×1.1

ONCOL

102 ×1.0

PRM

46 ×0.6

IMMUN

57 ×0.8

SURGE

Citations per year, relative to Takahiro Osuga Takahiro Osuga (= 1×) peers Naotaka Hayasaka

Countries citing papers authored by Takahiro Osuga

Since Specialization

Citations

This map shows the geographic impact of Takahiro Osuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Osuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Osuga more than expected).

Fields of papers citing papers by Takahiro Osuga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Osuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Osuga. The network helps show where Takahiro Osuga may publish in the future.

Co-authorship network of co-authors of Takahiro Osuga

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Osuga. A scholar is included among the top collaborators of Takahiro Osuga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Osuga. Takahiro Osuga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osuga, Takahiro, Koji Miyanishi, Ryo Ito, et al.. (2025). Hepatocellular Carcinoma Presenting with Pseudoprogression in a Patient Receiving Atezolizumab Plus Bevacizumab Combination Therapy. Internal Medicine. 64(14). 2148–2154.

Ito, Ryo, Koji Miyanishi, Tomohiro Kubo, et al.. (2023). Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma. Hepatology International. 17(3). 735–744. 11 indexed citations

Osuga, Takahiro, Koji Miyanishi, Shingo Tanaka, et al.. (2023). Occurrence of Autoimmune Encephalitis in a Patient with Hepatocellular Carcinoma after Atezolizumab and Bevacizumab Combination Therapy: A Case Study. Kanzo. 64(11). 559–566. 1 indexed citations

Osuga, Takahiro, Koji Miyanishi, Ryo Ito, et al.. (2022). A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib. SHILAP Revista de lepidopterología. 15(1). 318–325. 3 indexed citations

Osuga, Takahiro, Koji Miyanishi, Shingo Tanaka, et al.. (2022). A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome. SHILAP Revista de lepidopterología. 10(2). e05337–e05337. 1 indexed citations

Sakamoto, Hiroki, Koji Miyanishi, Shingo Tanaka, et al.. (2021). MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model. Scientific Reports. 11(1). 3599–3599. 6 indexed citations

Miyanishi, Koji, Takahiro Osuga, Shingo Tanaka, et al.. (2021). Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy. JGH Open. 5(12). 1335–1343. 10 indexed citations

Hayasaka, Naotaka, Kohichi Takada, Hajime Nakamura, et al.. (2019). Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells. Scientific Reports. 9(1). 5759–5759. 145 indexed citations

Okagawa, Yutaka, Kohichi Takada, Yohei Arihara, et al.. (2016). Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells. PLoS ONE. 11(12). e0168355–e0168355. 10 indexed citations

10.

Ono, Michihiro, Rishu Takimoto, Takahiro Osuga, et al.. (2016). Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin. Oncotarget. 7(25). 38586–38597. 8 indexed citations

11.

Sato, Yasushi, Hiroyuki Ohnuma, Masahiro Hirakawa, et al.. (2015). A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 75(3). 587–594. 7 indexed citations

12.

Ohnuma, Hiroyuki, Yasushi Sato, Masahiro Hirakawa, et al.. (2015). A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(2). 382–390. 5 indexed citations

13.

Tamura, Fumito, Yasushi Sato, Masahiro Hirakawa, et al.. (2014). RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells. Gastric Cancer. 19(1). 85–97. 39 indexed citations

14.

Kogawa, Takahiro, Mototsugu Shimokawa, Tamer M. Fouad, et al.. (2014). Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer. Targeted Oncology. 10(1). 125–133. 13 indexed citations

15.

Sato, Yasushi, Tamotsu Sagawa, Masahiro Hirakawa, et al.. (2014). Clinical utility of capsule endoscopy with flexible spectral imaging color enhancement for diagnosis of small bowel lesions. SHILAP Revista de lepidopterología. 2(2). E80–E87. 32 indexed citations

16.

Kato, Junji, Rishu Takimoto, Takahiro Osuga, et al.. (2014). Abstract 4463: Targeting SN38 delivery to gastrointestinal cancer cells using a fucose-bound nanoparticle approach. Cancer Research. 74(19_Supplement). 4463–4463. 1 indexed citations

17.

Hirakawa, Masahiro, Rishu Takimoto, Fumito Tamura, et al.. (2013). Fucosylated TGF-β receptors transduces a signal for epithelial–mesenchymal transition in colorectal cancer cells. British Journal of Cancer. 110(1). 156–163. 71 indexed citations

18.

Yoshida, Makoto, Rishu Takimoto, Kazuyuki Murase, et al.. (2012). Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach. PLoS ONE. 7(7). e39545–e39545. 48 indexed citations

19.

Osuga, Takahiro, Takahiro Kogawa, Tomohiro Kimura, et al.. (2012). [Evaluation of skin toxicity caused by cetuximab related to its clinical response].. PubMed. 39(8). 1221–5.

20.

Koyama, Shouhei, Koichi Suzuki, Yasuo Komatsu, et al.. (1983). [Autopsy case of pancreatic carcinoma associated with B-cell derived lymphoma].. PubMed. 29(2). A–11, 168.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact